Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 15/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 11/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 8/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.44 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19030851 | 0.85 | HDAC4 (0.50) | HDAC6HDAC1HDAC8HDAC4 | |
| SCHEMBL19030850 | 0.85 | HDAC4 (0.50) | HDAC6HDAC1HDAC8HDAC4 | |
| SCHEMBL19861945 | 0.85 | HDAC4 (0.50) | HDAC6HDAC1HDAC8HDAC4 | |
| SCHEMBL21215382 | 0.84 | HDAC6 (0.47) | HDAC6HDAC1HDAC8HDAC5HDAC4 | |
| SCHEMBL21215369 | 0.80 | HDAC1 (0.50) | HDAC6HDAC1HDAC8HDAC5 | |
| SCHEMBL21215295 | 0.80 | HDAC6 (0.49) | HDAC6HDAC1HDAC8HDAC5HDAC4 | |
| SCHEMBL19861924 | 0.80 | HDAC6 (0.43) | HDAC6HDAC1HDAC8HDAC5HDAC4 | |
| SCHEMBL19861927 | 0.80 | HDAC6 (0.47) | HDAC6HDAC1HDAC8HDAC5HDAC4 | |
| SCHEMBL19861940 | 0.80 | HDAC4 (0.43) | HDAC6HDAC1HDAC8HDAC5HDAC4 | |
| SCHEMBL19861933 | 0.80 | HDAC1 (0.43) | HDAC6HDAC1HDAC8HDAC5HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10980233-B2 | Oxadiazole compound and use thereof as pesticides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-04-20 | — | — | US | disclosed |
| US-20190230928-A1 | OXADIAZOLE COMPOUND AND USE THEREOF AS PESTICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-08-01 | — | — | US | disclosed |
| WO-2018030460-A1 | OXADIAZOLE COMPOUND AND USE THEREOF AS PESTICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10980233-B2 | Oxadiazole compound and use thereof as pesticides | RXFP3, OXER1, OXA1L | HDAC6 1746/4885HDAC1 660/4885HDAC8 2524/4885 |
| US-20190230928-A1 | OXADIAZOLE COMPOUND AND USE THEREOF AS PESTICIDES | RXFP3, OXER1, OXA1L | HDAC6 1746/4885HDAC1 660/4885HDAC8 2524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.